Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Thursday. The firm set a “hold” rating on the stock.

Milestone Scientific Stock Up 7.3 %

NYSE:MLSS opened at $1.00 on Thursday. The firm has a market capitalization of $77.08 million, a PE ratio of -9.98 and a beta of 0.88. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.19. The firm has a 50-day moving average price of $0.85 and a 200 day moving average price of $0.73.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). The firm had revenue of $1.85 million during the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%.

Insiders Place Their Bets

In related news, Director Leonard Osser sold 141,913 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $0.95, for a total value of $134,817.35. Following the transaction, the director now directly owns 4,602,506 shares in the company, valued at $4,372,380.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 24.75% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.